Literature DB >> 22309282

Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells.

R Ramasamy1, C K Tong, W K Yip, S Vellasamy, B C Tan, H F Seow.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSC) have great potential in regenerative medicine, immunotherapy and gene therapy due to their unique properties of self-renewal, high plasticity, immune modulation and ease for genetic modification. However, production of MSC at sufficient clinical scale remains an issue as in vitro generation of MSC inadequately fulfils the demand with respect to patients.
OBJECTIVES: This study has aimed to establish optimum conditions to generate and characterize MSC from human umbilical cord (UC-MSC).
MATERIALS AND METHODS: To optimize MSC population growth, basic fibroblast growth factor (bFGF) was utilized in culture media. Effects of bFGF on expansion kinetics, cell cycle, survival of UC-MSC, cytokine secretion, expression of early stem-cell markers and immunomodulation were investigated.
RESULTS: bFGF supplementation profoundly enhanced UC-MSC proliferation by reducing population doubling time without altering immunophenotype and immunomodulatory function of UC-MSC. However, cell cycle studies revealed that bFGF drove the cells into the cell cycle, as a higher proportion of cells resided in S phase and progressed into M phase. Consistent with this, bFGF was shown to promote expression of cyclin D proteins and their relevant kinases to drive UC-MSC to transverse cell cycle check points, thus, committing the cells to DNA synthesis. Furthermore, supplementation with bFGF changed the cytokine profiles of the cells and reduced their apoptotic level.
CONCLUSION: Our study showed that bFGF supplementation of UC-MSC culture enhanced the cells' growth kinetics without compromising their nature.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309282      PMCID: PMC6495492          DOI: 10.1111/j.1365-2184.2012.00808.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  35 in total

1.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

2.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

Review 3.  G1 events and regulation of cell proliferation.

Authors:  A B Pardee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Anti-proliferative and anti-invasive properties of a purified fraction from Streptomyces sp. H7372.

Authors:  Wai Kien Yip; Sarot Cheenpracha; Leng Chee Chang; Coy Choke Ho; Heng Fong Seow
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

5.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

7.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

8.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

9.  Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.

Authors:  K Hanada; J E Dennis; A I Caplan
Journal:  J Bone Miner Res       Date:  1997-10       Impact factor: 6.741

10.  ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential.

Authors:  Iván Cárcamo-Orive; Naiara Tejados; Jesús Delgado; Ainhoa Gaztelumendi; David Otaegui; Valerie Lang; César Trigueros
Journal:  Exp Cell Res       Date:  2008-02-06       Impact factor: 3.905

View more
  15 in total

1.  Phenotypic differences in early outgrowth angiogenic cells based on in vitro cultivation.

Authors:  Tyler D Bammert; Collin A Beckstrom; Grace Lincenberg; Jamie G Hijmans; Jared J Greiner; Natalia G Rocha
Journal:  Cytotechnology       Date:  2019-02-12       Impact factor: 2.058

2.  LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.

Authors:  Justin C Paglino; Koray Ozduman; Anthony N van den Pol
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

3.  Human umbilical cord-derived MSC culture: the replacement of animal sera with human cord blood plasma.

Authors:  Yan Ding; Hua Yang; Jing Bo Feng; Ying Qiu; Dong Sheng Li; Yi Zeng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-09-17       Impact factor: 2.416

4.  FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential.

Authors:  S Hagmann; B Moradi; S Frank; T Dreher; P W Kämmerer; W Richter; T Gotterbarm
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

5.  Basic fibroblast growth factor expression is implicated in mesenchymal stem cells response to light-induced retinal injury.

Authors:  Wei Xu; Xiaoting Wang; Guoxing Xu; Jian Guo
Journal:  Cell Mol Neurobiol       Date:  2013-09-13       Impact factor: 5.046

Review 6.  Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial.

Authors:  Antonin Bukovsky; Michael R Caudle
Journal:  Reprod Biol Endocrinol       Date:  2012-11-23       Impact factor: 5.211

7.  Combined influence of basal media and fibroblast growth factor on the expansion and differentiation capabilities of adipose-derived stem cells.

Authors:  Mark Ahearne; Joanne Lysaght; Amy P Lynch
Journal:  Cell Regen (Lond)       Date:  2014-11-26

8.  Attachment and Differentiation of Human Umbilical Cord Stem Cells on to the Tooth Root Surface with and without the Use of Fibroblast Growth Factor-An In Vitro Study.

Authors:  Joann Pauline George; Pornika Chakravarty; Kamedh Yashawant Chowdhary; H Purushothama; Jyothsna A Rao
Journal:  Int J Stem Cells       Date:  2015-05       Impact factor: 2.500

9.  Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.

Authors:  Andrea Lindenmair; Tim Hatlapatka; Gregor Kollwig; Simone Hennerbichler; Christian Gabriel; Susanne Wolbank; Heinz Redl; Cornelia Kasper
Journal:  Cells       Date:  2012-11-12       Impact factor: 6.600

10.  The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?

Authors:  Zahra Vojdani; Ali Babaei; Attiyeh Vasaghi; Mojtaba Habibagahi; Tahereh Talaei-Khozani
Journal:  Iran J Basic Med Sci       Date:  2016-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.